Adults who want brand-name, FDA-approved GLP-1s with transparent cash pricing or help using commercial insurance, and who are comfortable with an online, message-based model.
- Starting price
- $39 first month membership
- Consult model
- Asynchronous (questionnaire + messaging)
- Prescriber
- MD/DO + NP/PA
- Labs
- Included
- Insurance
- Accepted
- Availability
- 50 states + DC
- Cancellation
- Self-serve online
- Founded
- 2017 · New York, NY
Pricing
Ro Body membership costs $39 for the first month, then $149/mo on a monthly plan, or $99, $89 or $74/mo prepaid for 3, 6 or 12 months. Medication isn't included. Cash prices listed on 2026-10-17: Wegovy pill $149-$299, Wegovy pen $199 (first two months, limited-time) then $349-$399, Zepbound KwikPen $299-$449 and Foundayo $149-$299. Insurance is also an option for Wegovy, Zepbound and Ozempic pens. The membership includes lab testing 'if necessary' (a Quest metabolic panel).
Prices as listed on October 17, 2026. They change often; confirm at checkout.
What we like
- Lists only FDA-approved branded GLP-1s (Wegovy, Zepbound, Ozempic, Foundayo), with no compounded versions
- Cash price for every medication dose is published on its pricing page
- Insurance concierge checks coverage and handles prior authorization for GLP-1 pens
- Metabolic lab test at Quest included in the membership fee
Watch out for
- Membership ($149/mo monthly) is billed on top of medication
- Membership fees are non-refundable once paid, including prepaid multi-month plans
- Can't coordinate GLP-1 coverage for government insurance plans
- 747 BBB complaints in the last 3 years
Cancelling
Per the Terms of Use, revised 2026-04-02: cancel in your account under Ro Body Program > Program Details > 'Cancel Subscription', or by email. You must cancel at least 48 hours before the next renewal date. Access continues through the paid cycle. Once paid, membership fees are non-refundable. The $39 first month is refunded if you're found ineligible for GLP-1s.
Where it is available
All 50 states + DC (based on a Ro-affiliated job listing and ConsumerAffairs, not a ro.co service-area page; drug options may vary by state)
- 2025-04 Telephone Consumer Protection Act suit (Wilson v. Roman Health Ventures, S.D.N.Y.) filed; dismissed Oct 2025 after a reported settlement in principle. Source ↗
